Robeco Institutional Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,329
Closed -$214K 967
2022
Q1
$214K Hold
4,329
﹤0.01% 841
2021
Q4
$220K Hold
4,329
﹤0.01% 836
2021
Q3
$242K Hold
4,329
﹤0.01% 833
2021
Q2
$185K Hold
4,329
﹤0.01% 887
2021
Q1
$180K Hold
4,329
﹤0.01% 884
2020
Q4
$202K Hold
4,329
﹤0.01% 853
2020
Q3
$184K Hold
4,329
﹤0.01% 849
2020
Q2
$208K Hold
4,329
﹤0.01% 886
2020
Q1
$199K Hold
4,329
﹤0.01% 888
2019
Q4
$260K Sell
4,329
-2,791
-39% -$166K ﹤0.01% 883
2019
Q3
$403K Buy
7,120
+4,870
+216% +$274K ﹤0.01% 855
2019
Q2
$126K Hold
2,250
﹤0.01% 929
2019
Q1
$114K Hold
2,250
﹤0.01% 925
2018
Q4
$90K Hold
2,250
﹤0.01% 925
2018
Q3
$156K Buy
+2,250
New +$171K ﹤0.01% 924

Other funds holding EGRX